{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:05Z","timestamp":1787009945780,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1097\/dad.0000000000002352","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:44:49Z","timestamp":1675341889000},"page":"189-191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Drug-Induced Linear IgA Bullous Dermatosis Mimicking Stevens\u2013Johnson Syndrome Treated With Etanercept: A Case Report"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-8524","authenticated-orcid":false,"given":"Bradley D.","family":"Kwinta","sequence":"first","affiliation":[{"name":"Columbia University, Vagelos College of Physicians and Surgeons, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Queen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Irving Medical Center, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Husain","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Division of Dermatopathology, Columbia University Irving Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Gallitano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Irving Medical Center, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.sder.2010.03.005","article-title":"Autoimmune blistering diseases in children","volume":"29","author":"Lara-Corrales","year":"2010","journal-title":"Semin Cutan Med Surg."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000353584","article-title":"Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature","volume":"227","author":"Kakar","year":"2013","journal-title":"Dermatology"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal","year":"2013","journal-title":"Br J Dermatol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ced.13030","article-title":"Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap","volume":"42","author":"Adler","year":"2017","journal-title":"Clin Exp Dermatol."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D3238036012","article-title":"Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"23","author":"Baltazard","year":"2017","journal-title":"Dermatol Online J."},{"key":"R8-20250616","first-page":"176","article-title":"Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis","volume":"62","author":"Nasr","year":"2014","journal-title":"J Med Liban"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjd.15400","article-title":"Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment","volume":"178","author":"Prieto-Barrios","year":"2018","journal-title":"Br J Dermatol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000431172","article-title":"Linear IgA bullous dermatosis secondary to infliximab therapy in a patient with ulcerative colitis","volume":"231","author":"Hoffmann","year":"2015","journal-title":"Dermatology"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000355354","article-title":"Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab","volume":"227","author":"Yamada","year":"2013","journal-title":"Dermatology"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"The Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium. Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2002.120563","article-title":"Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity","volume":"109","author":"Posadas","year":"2002","journal-title":"J Allergy Clin Immunol."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000372-199704000-00005","article-title":"Erythema multiforme and toxic epidermal necrolysis: a comparative study","volume":"19","author":"Paquet","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/jid.2012.330","article-title":"TNF-\u03b1 and IFN-\u03b3 are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis","volume":"133","author":"Viard-Leveugle","year":"2013","journal-title":"J Invest Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:04:42Z","timestamp":1750082682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002352","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"2022-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}